My Companies
Notification
Account
Board approved preferential issue of up to 5,50,000 warrants at Rs172 each for up to Rs9.46 Cr to 3 promoter-group allottees, plus EGM on Oct 23 with record date Oct 16. Promoter-only take at premium to floor signals commitment; funds shift from asset-light D2C toward hospitals and owned manufacturing where capex and cash conversion are key. Only 25% payable now, 75% on conversion within 18 months; needs shareholder and regulatory nod. Dilution modest, promoter holding to 55.5%; exact use beyond healthcare platform not detailed.